<DiagnosticReport xmlns="http://hl7.org/fhir">
  <id value="core-examples-DiagnosticReport-example156" />
  <meta>
    <versionId value="3" />
    <lastUpdated value="2016-09-08T12:22:50.141+00:00" />
  </meta>
  <text>
    <status value="generated" />
    <div xmlns="http://www.w3.org/1999/xhtml">
      <pre>
Anti-Factor Xa Assay (Plasma)
Heparin Level by Anti-Xa          0.07   U/mL

Anti-Factor Xa Comment:
   Reference range for Anti-Xa level depends upon route, time, dose and
   reason for anticoagulation.
   Therapeutic anticoagulation with LMWH (such as Enoxaparin) generally does
   not require routine monitoring. However, anti-Xa levels are recommended
   for patients on LMWH requiring dose adjustment in settings of (1) renal
   impairment, (2) obesity and (3) pregnancy.  To assist interpretation of
   therapeutic ranges, anti-Xa levels should be collected four hours after
   the third dose.  For less common indications such a patients at high risk
   of bleeding, and interpretation of results, please contact the on-call
   laboratory Haematology registrar or Haematologist via ACME switchboard.

Tests of Hypercoagulability (Plasma)
Antithrombin (Functional)         88     %      (80-120)
</pre>
    </div>
  </text>
  <identifier>
    <system value="http://acme.com/lab/reports" />
    <value value="12Z986818-16258584" />
  </identifier>
  <status value="final" />
  <code>
    <text value="Special Coagulation" />
  </code>
  <subject>
    <reference value="Patient/155" />
  </subject>
  <effectiveDateTime value="2012-04-05T20:10:00Z" />
  <issued value="2012-04-05T22:07:00+00:00" />
  <performer>
    <reference value="Organization/1832473e-2fe0-452d-abe9-3cdb9879522f" />
    <display value="Acme Laboratory, Inc" />
  </performer>
</DiagnosticReport>